Non Regulatory September 9, 2021Nanoform technology delivers successful results for Herantis CDNF drug candidate
Regulatory August 27, 2021The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key employees
Regulatory August 26, 2021Nanoform Interim Report January – June 2021
Nanoform Finland Plc (“Nanoform”), published its Q2/2021 report on August 26, 2021, at 8.10 a.m. Finnish time / 7.10 a.m. Swedish time. The company will hold a conference call and an online presentation on the same day at 3.00 p.m. Finnish time / 2.00 p.m. Swedish time.